Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z. Wang(University Health Network), Gelareh Zadeh(University Health Network)
Cited by 8
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
|Nature Medicine|2020|270
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
|Clinical Epigenetics|2019|89
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification
|Neuro-Oncology|2022|69
DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma
|Neuro-Oncology|2021|62